These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 26910390)
1. Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Cho K; Moon JS; Kang JH; Jang HB; Lee HJ; Park SI; Yu KS; Cho JY Pediatr Obes; 2017 Apr; 12(2):93-101. PubMed ID: 26910390 [TBL] [Abstract][Full Text] [Related]
2. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity. Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090 [TBL] [Abstract][Full Text] [Related]
3. Urinary metabolomic profiling for noninvasive diagnosis of acute T cell-mediated rejection after kidney transplantation. Kim SY; Kim BK; Gwon MR; Seong SJ; Ohk B; Kang WY; Lee HW; Jung HY; Cho JH; Chung BH; Lee SH; Kim YH; Yoon YR; Kim CD; Cho S J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():157-163. PubMed ID: 31054449 [TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Khamis MM; Adamko DJ; El-Aneed A Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008 [TBL] [Abstract][Full Text] [Related]
5. Effect of weight loss interventions on metabolomic signatures in obese children with insulin resistance. Liu X; Zhu L; Liu J; Nie Z; Qiu W Amino Acids; 2024 Aug; 56(1):54. PubMed ID: 39212734 [TBL] [Abstract][Full Text] [Related]
6. Identification of pathognomonic purine synthesis biomarkers by metabolomic profiling of adolescents with obesity and type 2 diabetes. Concepcion J; Chen K; Saito R; Gangoiti J; Mendez E; Nikita ME; Barshop BA; Natarajan L; Sharma K; Kim JJ PLoS One; 2020; 15(6):e0234970. PubMed ID: 32589682 [TBL] [Abstract][Full Text] [Related]
7. Metabolomics analysis reveals altered metabolites in lean compared with obese adolescents and additional metabolic shifts associated with hyperinsulinaemia and insulin resistance in obese adolescents: a cross-sectional study. Müllner E; Röhnisch HE; von Brömssen C; Moazzami AA Metabolomics; 2021 Jan; 17(1):11. PubMed ID: 33438144 [TBL] [Abstract][Full Text] [Related]
8. Global metabolomic profiling targeting childhood obesity in the Hispanic population. Butte NF; Liu Y; Zakeri IF; Mohney RP; Mehta N; Voruganti VS; Göring H; Cole SA; Comuzzie AG Am J Clin Nutr; 2015 Aug; 102(2):256-67. PubMed ID: 26085512 [TBL] [Abstract][Full Text] [Related]
9. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry. Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052 [TBL] [Abstract][Full Text] [Related]
10. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry. Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313 [TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of potential urine biomarkers of respiratory illnesses using new targeted metabolomic approach. Khamis MM; Adamko DJ; Purves RW; El-Aneed A Anal Chim Acta; 2019 Jan; 1047():81-92. PubMed ID: 30567667 [TBL] [Abstract][Full Text] [Related]
12. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions. Lam CW; Law CY J Proteome Res; 2014 Sep; 13(9):4040-6. PubMed ID: 25117182 [TBL] [Abstract][Full Text] [Related]
13. Short-term high-fat diet exacerbates insulin resistance and glycolipid metabolism disorders in young obese men with hyperlipidemia, as determined by metabolomics analysis using ultra-HPLC-quadrupole time-of-flight mass spectrometry. Feng R; Sun G; Zhang Y; Sun Q; Ju L; Sun C; Wang C J Diabetes; 2019 Feb; 11(2):148-160. PubMed ID: 30058212 [TBL] [Abstract][Full Text] [Related]
14. A HILIC-UHPLC-MS/MS untargeted urinary metabonomics combined with quantitative analysis of five polar biomarkers on osteoporosis rats after oral administration of Gushudan. Wu X; Huang Y; Sun J; Wen Y; Qin F; Zhao L; Xiong Z J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():40-49. PubMed ID: 29132024 [TBL] [Abstract][Full Text] [Related]
15. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling. Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054 [TBL] [Abstract][Full Text] [Related]
16. Untargeted metabolomics approach (UPLC-Q-TOF-MS) explores the biomarkers of serum and urine in overweight/obese young men. Yu HT; Fu XY; Xu B; Zuo LL; Ma HB; Wang SR Asia Pac J Clin Nutr; 2018; 27(5):1067-1076. PubMed ID: 30272855 [TBL] [Abstract][Full Text] [Related]
17. Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children. Martos-Moreno GÁ; Mastrangelo A; Barrios V; García A; Chowen JA; Rupérez FJ; Barbas C; Argente J Int J Obes (Lond); 2017 Oct; 41(10):1473-1480. PubMed ID: 28588306 [TBL] [Abstract][Full Text] [Related]
18. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches. More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381 [TBL] [Abstract][Full Text] [Related]
19. A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients. Solmaz İ; Kaplan O; Çelebier M; Lay İ; Anlar B Turk J Med Sci; 2022 Aug; 52(4):1299-1310. PubMed ID: 36326407 [TBL] [Abstract][Full Text] [Related]